Codexis (CDXS) Net Cash Flow (2010 - 2026)
Codexis (CDXS) recorded quarterly Net Cash Flow of -$14.3 million in Q1 2026, down 154.94% quarter-over-quarter from $26.0 million in Q4 2025, and down 1412.18% on a YoY basis from $1.1 million in Q1 2025.
Codexis (CDXS) Net Cash Flow (2010 - 2026) Analysis & Trends
Codexis' Net Cash Flow history runs 17 years deep, the most recent figure standing at -$14.3 million for Q1 2026.
- In Q1 2026, Net Cash Flow fell 1412.18% year-over-year to -$14.3 million; the TTM figure through Mar 2026 stood at $18.7 million (up 147.11% YoY), while the FY2025 annual figure was $32.1 million, up 169.88% from the prior year.
- Net Cash Flow was -$14.3 million for Q1 2026 at Codexis, down from $26.0 million in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $26.0 million in Q4 2025 to a low of -$39.5 million in Q2 2024.
- Historically, Net Cash Flow has averaged -$4.7 million across 5 years, with a median of -$7.1 million in 2024.
- The sharpest annual moves came in 2022 and 2026: Net Cash Flow surged 320.93% in 2022, then sank 1412.18% in 2026.
- A 5-year view of Net Cash Flow shows it stood at $5.3 million in 2022, then sank by 287.8% to -$9.9 million in 2023, then tumbled by 83.22% to -$18.2 million in 2024, then soared by 242.78% to $26.0 million in 2025, then slumped by 154.94% to -$14.3 million in 2026.
- The last three Net Cash Flow figures came in at -$14.3 million (Q1 2026), $26.0 million (Q4 2025), and -$1.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 2.44 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 625.70 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -2.44 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 457.40 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 664,983.53 |
| 10 | Codexis | 236.00 Mn | 170.86 Mn | 13.18 Mn | -14.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14.28 Mn |
| Mar 31, 2026 | -14.28 Mn |
| Dec 31, 2025 | 25.99 Mn |
| Dec 31, 2025 | 25.99 Mn |
| Sep 30, 2025 | -1.43 Mn |
| Sep 30, 2025 | -1.43 Mn |
| Jun 30, 2025 | 8.44 Mn |
| Jun 30, 2025 | 8.44 Mn |
| Mar 31, 2025 | -944,000.00 |
| Mar 31, 2025 | -944,000.00 |
| Dec 31, 2024 | -18.20 Mn |
| Dec 31, 2024 | -18.20 Mn |
| Sep 30, 2024 | 18.85 Mn |
| Sep 30, 2024 | 18.85 Mn |
| Jun 30, 2024 | -39.45 Mn |
| Jun 30, 2024 | -39.45 Mn |
| Mar 31, 2024 | -7.07 Mn |
| Mar 31, 2024 | -7.07 Mn |
| Dec 31, 2023 | -9.93 Mn |
| Dec 31, 2023 | -9.93 Mn |